Amoxicillin: Clinical Uses, Dosing, and Adverse Effects
Primary Clinical Indications
Amoxicillin is a first-line penicillin-class antibiotic indicated for treating bacterial infections of the upper respiratory tract (otitis media, sinusitis, pharyngitis), lower respiratory tract (pneumonia, bronchitis), genitourinary tract, and skin/soft tissue infections caused by susceptible organisms. 1
Respiratory Tract Infections
- Acute otitis media: High-dose amoxicillin (80-90 mg/kg/day in children, 500-1000 mg three times daily in adults) is the recommended first-line treatment 2, 3
- Acute bacterial sinusitis: Standard dose is 500 mg three times daily for 5-7 days in adults, or high-dose (80-90 mg/kg/day) in children with risk factors 2, 3
- Community-acquired pneumonia: 500 mg three times daily for 7-10 days in mild-to-moderate cases 3
- Streptococcal pharyngitis: 500 mg twice daily for 10 days 3
Genitourinary Infections
- Uncomplicated urinary tract infections: Single 3-gram dose is effective in adults 4
- Complicated UTIs: Standard dosing of 500 mg three times daily for 7-10 days 1
Other Indications
- Helicobacter pylori eradication: 1 gram twice daily with clarithromycin and lansoprazole for 14 days (triple therapy) 1
- Lyme disease (erythema migrans): 500 mg three times daily for 14-21 days 3
- Gonorrhea: Effective as single-dose therapy 5
Standard Dosing Regimens
Adult Dosing
- Mild-to-moderate infections: 500 mg orally three times daily or 250 mg every 8 hours 2, 3, 1
- Severe infections or resistant organisms: 1000 mg three times daily 3
- High-risk patients (age >65, recent antibiotic use, areas with >10% penicillin-resistant S. pneumoniae): 2000 mg twice daily 3
- Maximum adult dose: 1750 mg/day in divided doses 1
Pediatric Dosing (>3 months)
- Standard dose: 20-45 mg/kg/day divided every 8-12 hours 1
- High-dose regimen (for resistant organisms): 80-90 mg/kg/day divided twice daily 2, 6
- Neonates and infants ≤3 months: Maximum 30 mg/kg/day divided every 12 hours 1
- Children <40 kg with mild-moderate skin infections: 25 mg/kg/day every 12 hours or 20 mg/kg/day every 8 hours 2
- Children ≥40 kg: 500 mg every 12 hours or 250 mg every 8 hours 2
When to Use High-Dose Amoxicillin
High-dose therapy is indicated when there are risk factors for resistant organisms 2, 3:
- Recent antibiotic use within 30 days
- Daycare attendance (children)
- Age <2 years or >65 years
- Geographic areas with >10% penicillin-resistant S. pneumoniae
- Treatment failure with standard dosing
- Severe or complicated infections
Renal Dosing Adjustments
When to Use Amoxicillin-Clavulanate Instead
Switch to amoxicillin-clavulanate when β-lactamase-producing organisms are suspected or confirmed, including H. influenzae, M. catarrhalis, or S. aureus. 3, 7
Specific Indications for Amoxicillin-Clavulanate
- Recent antibiotic use within 30 days 2, 8
- Concurrent purulent conjunctivitis (otitis-conjunctivitis syndrome) 2, 6
- Treatment failure with amoxicillin alone 2, 3
- Animal or human bite wounds 3
- β-lactamase-producing pathogens documented or suspected 2, 7
Dosing for Amoxicillin-Clavulanate
- Adults: 875/125 mg twice daily or 500/125 mg three times daily; high-dose is 2000/125 mg twice daily 2, 8
- Children: High-dose is 90 mg/kg/day amoxicillin with 6.4 mg/kg/day clavulanate in 2 divided doses (14:1 ratio) 2, 8, 6
- The 14:1 ratio formulation causes less diarrhea than other amoxicillin-clavulanate preparations 2, 6
Common Adverse Effects
Gastrointestinal (Most Common)
- Diarrhea: Occurs in approximately 5% more patients than placebo 2
- Nausea and vomiting: Common, generally mild 2, 1
- Abdominal pain: Reported in clinical trials 2
- Clostridioides difficile-associated diarrhea: Can range from mild diarrhea to fatal colitis; evaluate if diarrhea occurs 1
- Oral candidiasis: Secondary fungal overgrowth 2
Dermatologic
- Rash: Occurs in >1% of patients, approximately 5% more than placebo 2, 1
- Urticaria and pruritus: Common allergic manifestations 2
- Severe cutaneous adverse reactions (SCAR): Including Stevens-Johnson syndrome, toxic epidermal necrolysis, and erythema multiforme; discontinue immediately if rash progresses 2, 1
- Acute generalized exanthematous pustulosis: Rare but serious 2
Hypersensitivity Reactions
- Anaphylaxis: Serious and occasionally fatal reactions have been reported; discontinue immediately if occurs 1
- Serum sickness: Delayed hypersensitivity reaction 2
- Angioedema: Potentially life-threatening 2
Hematologic
- Eosinophilia, thrombocytopenia, anemia: Rare but documented 2
- Hemolytic anemia, agranulocytosis: Very rare 2
Neurologic
- Headache, dizziness: Common, generally mild 2, 1
- Seizures: Rare, more likely with high doses or renal impairment 2
- Behavioral changes, agitation, anxiety: Particularly in children 2
Hepatic
- Elevated liver enzymes (AST/ALT): Monitor in prolonged therapy 2
- Cholestatic jaundice, hepatitis: Rare but serious 2
Other
Important Drug Interactions
Contraindicated or Not Recommended
- Probenecid: Coadministration not recommended; increases amoxicillin levels by decreasing renal excretion 1
Requires Monitoring
- Oral anticoagulants (warfarin): May increase prothrombin time; monitor INR closely 2, 1
- Allopurinol: Increases risk of rash; use combination cautiously 2, 1
- Oral contraceptives: Amoxicillin may reduce efficacy; advise backup contraception 1
- Methotrexate: Amoxicillin may decrease methotrexate clearance 2
Other Interactions
- Tetracyclines: May antagonize bactericidal effects of amoxicillin 2
- Antacids (aluminum/magnesium): May decrease absorption 2
Critical Warnings and Contraindications
Absolute Contraindications
- History of serious hypersensitivity reaction (anaphylaxis, Stevens-Johnson syndrome) to amoxicillin or other β-lactams (penicillins or cephalosporins) 1
Penicillin Allergy Considerations
Cross-reactivity between penicillins and cephalosporins is lower than historically reported (<10%), and cephalosporins with distinct chemical structures (cefdinir, cefuroxime, cefpodoxime, ceftriaxone) are highly unlikely to cross-react. 2
- Differentiate immediate Type I hypersensitivity reactions from other less dangerous side effects 2
- Patients with non-immediate reactions may tolerate specific β-lactams 2
- For true penicillin allergy, alternatives include doxycycline, respiratory fluoroquinolones, or TMP-SMX depending on indication 2
Special Populations
- Pregnancy Category B: Generally safe; minimal risk to fetus 2
- Breastfeeding: Distributed into milk but minimal risk to infant; compatible with breastfeeding 2
- Renal impairment: Requires dose adjustment when GFR <30 mL/min 2, 1
Common Pitfalls to Avoid
Inappropriate Use
- Viral upper respiratory infections: The vast majority of URTIs are viral and do not benefit from antibiotics; prescribing antibiotics for viral URTIs increases adverse effects without benefit and promotes resistance 2, 6
- Nonspecific URI and common cold: Antibiotics provide no benefit and only expose patients to potential harm 2
- Monotherapy should be avoided in certain settings where combination therapy is indicated 2
Dosing Errors
- Underdosing in children: Using subtherapeutic doses (e.g., 80 mg for a 5-year-old) fails to achieve adequate concentrations and promotes resistance 6
- Not using high-dose regimen when indicated: Standard doses lead to treatment failure with resistant organisms 2, 6
- Incorrect suspension concentration: Verify 125/31 vs 250/62 formulation before calculating volume 6
Treatment Failure
- Failure to respond after 72 hours: Should prompt either a switch to alternative antimicrobial therapy or reevaluation with imaging, endoscopy, or culture 2, 8
- Not considering β-lactamase producers: Switch to amoxicillin-clavulanate if H. influenzae or M. catarrhalis suspected 2, 3
Resistance Concerns
- Antibiotic exposure early in life: May disrupt intestinal microbiota and contribute to long-term adverse health effects including inflammatory bowel disease, obesity, eczema, and asthma 2
- Promoting resistance: Use only when bacterial infection is proven or strongly suspected 1
- Antibiotics are responsible for >150,000 unplanned medical visits annually for medication-related adverse events in children 2